Dosing, Administration, and Risks/Benefits of Treatment Strategies for UC: A Patient’s Perspective

Download slides by Kaitlyn Francese, MSN, RN, OCN on considerations from patients’ perspectives for available treatment strategies for patients with advanced urothelial cancer.
person default
Kaitlyn Francese, MSN, RN, OCN
Format: Microsoft PowerPoint (.ppt)
File Size: 245 KB
Released: May 28, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb
Pfizer, Inc. and EMD Serono

Related Content

Short slideset on key trials and approvals for first-generation TRK inhibitors in NTRK fusion+ solid tumors, from Clinical Care Options (CCO)

George D. Demetri, MD Alexander Drilon, MD Released: October 15, 2021

Short expert slideset on when and how to test for NTRK fusions in various solid tumors, from Clinical Care Options (CCO)

George D. Demetri, MD Alexander Drilon, MD Released: October 8, 2021

Free video from Clinical Care Options (CCO) featuring expert discussion of the latest updates in androgen deprivation therapy for prostate cancer

Daniel W. Lin, MD Alicia K. Morgans, MD, MPH David F. Penson, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: October 6, 2021 Expired: October 5, 2022

On-demand webcast of live expert webinar on early-stage urothelial carcinoma including upper tract urothelial cancer, from Clinical Care Options (CCO)

Seth P. Lerner, MD
Program Director
Jean Hoffman-Censits, MD Surena Matin, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: October 4, 2021 Expired: October 3, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue